Cargando…
Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension
AIMS: Previous studies have found high sodium intake to be associated with increased risks of cardiovascular disease (CVD) and all-cause mortality among individuals with hypertension; findings on the effect of intake among individuals without hypertension have been equivocal. We aimed to compare the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076395/ https://www.ncbi.nlm.nih.gov/pubmed/35201347 http://dx.doi.org/10.1093/eurheartj/ehac059 |
_version_ | 1784701915217526784 |
---|---|
author | Zeng, Chao Rosenberg, Lynn Li, Xiaoxiao Djousse, Luc Wei, Jie Lei, Guanghua Zhang, Yuqing |
author_facet | Zeng, Chao Rosenberg, Lynn Li, Xiaoxiao Djousse, Luc Wei, Jie Lei, Guanghua Zhang, Yuqing |
author_sort | Zeng, Chao |
collection | PubMed |
description | AIMS: Previous studies have found high sodium intake to be associated with increased risks of cardiovascular disease (CVD) and all-cause mortality among individuals with hypertension; findings on the effect of intake among individuals without hypertension have been equivocal. We aimed to compare the risks of incident CVD and all-cause mortality among initiators of sodium-containing acetaminophen with the risk of initiators of non-sodium-containing formulations of the same drug according to the history of hypertension. METHODS AND RESULTS: Using The Health Improvement Network, we conducted two cohort studies among individuals with and without hypertension. We examined the relation of sodium-containing acetaminophen to the risk of each outcome during 1-year follow-up using marginal structural models with an inverse probability weighting to adjust for time-varying confounders. The outcomes were incident CVD (myocardial infarction, stroke, and heart failure) and all-cause mortality. Among individuals with hypertension (mean age: 73.4 years), 122 CVDs occurred among 4532 initiators of sodium-containing acetaminophen (1-year risk: 5.6%) and 3051 among 146 866 non-sodium-containing acetaminophen initiators (1-year risk: 4.6%). The average weighted hazard ratio (HR) was 1.59 [95% confidence interval (CI) 1.32–1.92]. Among individuals without hypertension (mean age: 71.0 years), 105 CVDs occurred among 5351 initiators of sodium-containing acetaminophen (1-year risk: 4.4%) and 2079 among 141 948 non-sodium-containing acetaminophen initiators (1-year risk: 3.7%), with an average weighted HR of 1.45 (95% CI 1.18–1.79). Results of specific CVD outcomes and all-cause mortality were similar. CONCLUSION: The initiation of sodium-containing acetaminophen was associated with increased risks of CVD and all-cause mortality among individuals with or without hypertension. Our findings suggest that individuals should avoid unnecessary excessive sodium intake through sodium-containing acetaminophen use. |
format | Online Article Text |
id | pubmed-9076395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-90763952022-05-09 Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension Zeng, Chao Rosenberg, Lynn Li, Xiaoxiao Djousse, Luc Wei, Jie Lei, Guanghua Zhang, Yuqing Eur Heart J Clinical Research AIMS: Previous studies have found high sodium intake to be associated with increased risks of cardiovascular disease (CVD) and all-cause mortality among individuals with hypertension; findings on the effect of intake among individuals without hypertension have been equivocal. We aimed to compare the risks of incident CVD and all-cause mortality among initiators of sodium-containing acetaminophen with the risk of initiators of non-sodium-containing formulations of the same drug according to the history of hypertension. METHODS AND RESULTS: Using The Health Improvement Network, we conducted two cohort studies among individuals with and without hypertension. We examined the relation of sodium-containing acetaminophen to the risk of each outcome during 1-year follow-up using marginal structural models with an inverse probability weighting to adjust for time-varying confounders. The outcomes were incident CVD (myocardial infarction, stroke, and heart failure) and all-cause mortality. Among individuals with hypertension (mean age: 73.4 years), 122 CVDs occurred among 4532 initiators of sodium-containing acetaminophen (1-year risk: 5.6%) and 3051 among 146 866 non-sodium-containing acetaminophen initiators (1-year risk: 4.6%). The average weighted hazard ratio (HR) was 1.59 [95% confidence interval (CI) 1.32–1.92]. Among individuals without hypertension (mean age: 71.0 years), 105 CVDs occurred among 5351 initiators of sodium-containing acetaminophen (1-year risk: 4.4%) and 2079 among 141 948 non-sodium-containing acetaminophen initiators (1-year risk: 3.7%), with an average weighted HR of 1.45 (95% CI 1.18–1.79). Results of specific CVD outcomes and all-cause mortality were similar. CONCLUSION: The initiation of sodium-containing acetaminophen was associated with increased risks of CVD and all-cause mortality among individuals with or without hypertension. Our findings suggest that individuals should avoid unnecessary excessive sodium intake through sodium-containing acetaminophen use. Oxford University Press 2022-02-25 /pmc/articles/PMC9076395/ /pubmed/35201347 http://dx.doi.org/10.1093/eurheartj/ehac059 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Zeng, Chao Rosenberg, Lynn Li, Xiaoxiao Djousse, Luc Wei, Jie Lei, Guanghua Zhang, Yuqing Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
title | Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
title_full | Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
title_fullStr | Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
title_full_unstemmed | Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
title_short | Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
title_sort | sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076395/ https://www.ncbi.nlm.nih.gov/pubmed/35201347 http://dx.doi.org/10.1093/eurheartj/ehac059 |
work_keys_str_mv | AT zengchao sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension AT rosenberglynn sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension AT lixiaoxiao sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension AT djousseluc sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension AT weijie sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension AT leiguanghua sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension AT zhangyuqing sodiumcontainingacetaminophenandcardiovascularoutcomesinindividualswithandwithouthypertension |